Clinical disorders - Secondary hemostasis - Hemophilia

12 important questions on Clinical disorders - Secondary hemostasis - Hemophilia

What is the definition of hemophilia A and B?

A bleeding disorders that is caused by the deficiency of clotting factors FVIII (hemophilia A) or FIX (hemophilia B).

What is the classification of severity in hemophilia A and B patients?

  • Severe hemophilia: <1% active factor
  • Moderate hemophilia: <5% active factor
  • Mild hemophilia: 5-50% active factor

What are the symptoms of hemophilia?

  • Muscle and joint bleeds
  • Bleeds after trauma and surgery
  • Bleeds starts several hours after trauma
  • Higher grades + faster learning
  • Never study anything twice
  • 100% sure, 100% understanding
Discover Study Smart

What are the genetics principles of hemophilia?

Hemophilia is a X-linked recessive genetic disorder.

What are the 3 main treatment options for hemophilia and when do you use each medicine?

  1. Tranexaminic acid: when the patient has mucosal bleeds.
  2. DDAVP: patients with mild hemophilia A!
  3. Coagulation factor concentrate from plasma or recombinant
    • Hemophilia A --> supplementation FVIII
    • Hemophilia B --> supplementation FIX

What is the half-life time of supplementation FVIII and FIX

FVIII: 12 hours
FIX: 24 hours

What is the effect of administration of the coagulation factor for hemophilia A and B?

On-demand treatment is used when a bleedings occurs or surgery is needed.

The effect of administration of the coagulation factor is:
  • 1 unit FVIII/kg increases FVIII with 2%
  • 1 unit FIX/kg increases FIX with 1%

What is the aim for the on-demand treatment when a patients needs surgery?

The factor level that is necessary for surgery is 100%. This is accomplished on the day of the surgery with on-demand treatment. The factor supplementation is given intravenously.

The following days after the surgery, the factor levels needs to be:
  • Day 1: 80-100%
  • Day 2-5: 50-80%
  • Day 3: 30-50%  

What dosage of prophylaxes is given in patients with hemophilia A and B?

  • Hemophilia A: 3x/week 20-40 EH/kg with extended half-life product 2x/week 20-40 EH/kg
  • Hemophilia B: 2x/week 30-50 EH/kg with extended half-life product 1x/week 30-50 EH/kg

What are the 4 major complications of hemophilia treatment?

  • Infection agents: only in plasma, infections like hepatitis A,B,C, HIV, parvocirus and Creatzfield Jacob
  • Inhibitor development: development of alloantibodies directed against FVIII or FIX, which can lead to anaphylaxis or nephrotic syndrome.
  • Thrombosis: when you give too much factor concentrate or when the patient has a disease that already increases the risk of thrombosis.
  • Allergic reaction: to the factor concentrate

What do you measure when there is inhibitor development and how do you treat this?

You measure if the titer is high or low.

Low titer <5 BU
  • treatment: high dose of factor concentrate

High titer >5 BU
  • Bypassing agents: Feiba (activated prothrombin complex concentrate) or recombinant FVII
  • Immune tolerance induction: high dose of FVIII/FIX with corticosteroïds  

What are the risk factors of forming inhibitors against FVIII and FIX?

  • Race
  • Age
  • Family history
  • Start of prophylaxes, dosing, type of factor product
  • Type of mutation (intron 22 for FVIII and large gene deletion for FIX)

The question on the page originate from the summary of the following study material:

  • A unique study and practice tool
  • Never study anything twice again
  • Get the grades you hope for
  • 100% sure, 100% understanding
Remember faster, study better. Scientifically proven.
Trustpilot Logo